Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Psych MEQs / SAQsConsultation-liaison psychiatry

Psych MEQs / SAQs · Consultation-liaison psychiatry

Rapidly progressive dementia and prion disease (MEQ)

FRANZCP-style modified essay on rapidly progressive dementia: the tempo rule, the treatable-causes-first sieve, correct interpretation of CSF 14-3-3 and RT-QuIC, MRI and EEG performance, staged disclosure, infection-control and genetic counselling duties, and palliative planning.

20 marks20 min3 min readVerification in progress

Target exams

FRANZCPMRCPsychABPNMD-DNB
On this page
Study tools

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
You are the consultation-liaison psychiatrist. A 63-year-old accountant is referred from the medical ward as 'agitated depression, not responding to sertraline'. His wife dates the change to the second week of March, ten weeks ago: he has stopped driving, cannot find rooms in his own house, and startles violently at sudden noise. On examination he is ataxic and has stimulus-sensitive myoclonus. A junior doctor has already ordered a CSF 14-3-3, which is positive, and has told the family this means Creutzfeldt-Jakob disease. (i) Outline your assessment and investigation plan. (ii) Interpret the 14-3-3 result. (iii) State the treatable causes you must exclude and how. (iv) Describe how you would correct the disclosure and plan ongoing care, including infection control and genetic issues.
What the marker is looking for

Tempo recognised as the trigger for a rapidly progressive dementia work-up, treatable causes worked before prion disease, 14-3-3 interpreted honestly (sensitivity 92%, specificity 80%, not diagnostic), MRI requested with DWI and ADC, RT-QuIC named, and the premature disclosure corrected without throwing the junior under the bus.[11][12][14][16][17]

(i) Assessment and investigation — 6 marks

Start with tempo, not mood. Date-anchored collateral, a function-based timeline, and the question "what could he do three months ago that he cannot do today?" A family who can name a week is describing a rapidly progressive dementia, and that reordering of the differential is the mark-earning move.[11]

Examine as a physician. Startle myoclonus, gait and limb ataxia, cortical visual function, tone, reflexes and primitive reflexes — the signs that were present in prion-negative as well as prion-positive patients, and which are missed if you only take a psychiatric history.[12][1]

Investigations, sequenced:[11][1][2]

  • Bloods for reversible causes: B12, thiamine status, thyroid function, liver and renal function, calcium, glucose, syphilis and HIV serology, autoimmune and paraneoplastic screens.
  • MRI with DWI and ADC — the request that decides the diagnosis; a routine sequence set can be reported normal when DWI is diagnostic.
  • EEG, including consideration of non-convulsive status epilepticus.
  • CSF: cell count, protein, 14-3-3, total tau, RT-QuIC, cytology and autoimmune encephalitis antibodies.
  • PRNP sequencing where indicated, through the appropriate pathway.[1][2][13][17]
Psychiatry Fellowship Pro

Continue reading

You have read the opening of this meqs / saq. The complete unit — every section and its primary-source references — is part of the Psychiatry Fellowship fellowship library.

Sign in to continueSee pricing
References20ShowHide
  1. [1]Zerr I, Kallenberg K, Summers DM, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease Brain, 2009.PMID 19773352
  2. [2]Hermann P, Appleby B, Brandel JP, et al. Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease Lancet Neurol, 2021.PMID 33609480
  3. [3]Watson N, Brandel JP, Green A, et al. The importance of ongoing international surveillance for Creutzfeldt-Jakob disease Nat Rev Neurol, 2021.PMID 33972773
  4. [4]Ladogana A, Puopolo M, Croes EA, et al. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada Neurology, 2005.PMID 15883321
  5. [5]Appleby BS, Rincon-Beardsley TD, Appleby KK, et al. Initial diagnoses of patients ultimately diagnosed with prion disease J Alzheimers Dis, 2014.PMID 24934543
  6. [6]Zeidler M, Johnstone EC, Bamber RW, et al. New variant Creutzfeldt-Jakob disease: psychiatric features Lancet, 1997.PMID 9314868
  7. [7]Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK Lancet, 1996.PMID 8598754
  8. [8]Zeidler M, Sellar RJ, Collie DA, et al. The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease Lancet, 2000.PMID 10791525
  9. [9]Brown P, Brandel JP, Sato T, et al. Iatrogenic Creutzfeldt-Jakob disease, final assessment Emerg Infect Dis, 2012.PMID 22607808
  10. [10]Mead S, Hermann P, Mok TH, et al. Genetic causes and modifiers of prion diseases Lancet Neurol, 2026.PMID 41579904
  11. [11]Day GS Rapidly Progressive Dementia Continuum (Minneap Minn), 2022.PMID 35678409
  12. [12]Chitravas N, Jung RS, Kofskey DM, et al. Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease Ann Neurol, 2011.PMID 21674591
  13. [13]Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis Lancet Neurol, 2016.PMID 26906964
  14. [14]Vitali P, Maccagnano E, Caverzasi E, et al. Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias Neurology, 2011.PMID 21471469
  15. [15]Steinhoff BJ, Zerr I, Glatting M, et al. Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease Ann Neurol, 2004.PMID 15449324
  16. [16]Muayqil T, Gronseth G, Camicioli R Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology Neurology, 2012.PMID 22993290
  17. [17]Foutz A, Appleby BS, Hamlin C, et al. Diagnostic and prognostic value of human prion detection in cerebrospinal fluid Ann Neurol, 2017.PMID 27893164
  18. [18]Pocchiari M, Puopolo M, Croes EA, et al. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies Brain, 2004.PMID 15361416
  19. [19]Williams RT, White N, Kearns J, et al. Palliative care symptoms of people living with rapidly progressive prion diseases: a systematic review BMC Palliat Care, 2026.PMID 42046045
  20. [20]Stevenson M, Uttley L, Oakley JE, et al. Interventions to reduce the risk of surgically transmitted Creutzfeldt-Jakob disease: a cost-effective modelling review Health Technol Assess, 2020.PMID 32122460
Psychiatry Fellowship Pro

$29/ monthor $279 / year

The complete Psychiatry Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousPsycho-oncology: depression, interactions, delirium, and capacity (MEQ)Consultation-liaison psychiatryNextSSD, illness anxiety, and chronic pain dual diagnosis (MEQ)Consultation-liaison psychiatry